PharmaBro vs OpenLoop: the 2026 comparison

Most comparisons in this category argue about the size of a fee. This one is about direction, and it is worth reading slowly, because it is the part that surprises operators.

Under OpenLoop's terms, the patient enters a card on your interface. That charge is "deposited to OpenLoop's merchant account." OpenLoop then pays you a Membership Services Fee, "every Wednesday for the week ending Tuesday," calculated on OpenLoop's own count of net active patients.

So you are not a business that collects revenue and pays a vendor. You are a business that is paid a fee by a vendor, weekly, in arrears, against their reconciliation. Your brand, your creative, your ad account, your customer. Their merchant account, their count, their payment run.

On PharmaBro the arrow points the other way. Your brand connects its own Stripe account by OAuth. The patient's money lands in an account with your name on it, instantly, and you pay PharmaBro a published fee out of it. We never hold your funds and cannot delay your payout, because we are never in the path.

OpenLoop's GLP-1 pricing is set out per month, per product. The left column is what your patient pays. The middle is what OpenLoop's schedule pays you. The right is what stays with OpenLoop.

Semaglutide injection

Tirzepatide injection

Look down the last column rather than across the rows. Your share falls as the patient matures. Semaglutide takes you from 56.2% to 49.8%. Tirzepatide takes you from 57.8% to 40.7%, a seventeen-point collapse.

That is the opposite of how a subscription business is supposed to work. Month one is your expensive month: you paid to acquire that patient. Month twelve is the one you built the business for, no acquisition cost, pure contribution. It is precisely then that your share is smallest and theirs is largest.

The pattern is not confined to GLP-1. On the same schedules: microdosing $179 pays you $90. Sexual health ten-packs at $119 pay you $50. Hair loss at $65 pays you $28. A $35 biotin subscription pays you $11.

Hold one semaglutide patient for twelve months. They pay $2,988. OpenLoop's schedule pays you $1,514. OpenLoop keeps $1,474, or 49.3%.

Then subtract what you owe them regardless: a $9,000 implementation fee ($4,500 at signing, $4,500 on first patient seen), $1,500 a month for technology and systems access, and $3,000 for LegitScript through their integration path. All on a 12-month initial term.

Which reduces the entire decision to one checkable question. The gap above is worth about $113 per patient per month. So: does medication, labs and fulfillment for one patient cost you more than $113 a month, bought directly?

Ask any compounding pharmacy that question and you will have your answer in a single phone call. We are comfortable putting the decision there, because we know what the call returns. PharmaBro routes across 30+ pre-integrated pharmacies and takes nothing on the medication, so the number you get is the number you pay.

There is a second cost in the schedule that never appears as a line item: you do not set your retail price. $249 semaglutide, $339 tirzepatide, $279 oral, $179 microdosing. Both the patient's price and your share are fixed in OpenLoop's document.

That removes the single strongest lever a consumer brand has. You cannot test $299 against $249. You cannot run a premium tier, discount to win a channel, bundle, or price by cohort. Your margin is not something you build, it is something you are assigned.

On PharmaBro you set every price yourself and keep 100% of the difference between what you charge and what fulfillment costs. If you want to charge $399 because your brand can, that entire spread is yours. Our fee does not move.

Reading past the pricing pages, the proposal sets out a handful of constraints worth pricing into any comparison.

• Each new brand is a new contract. "Added business lines will require an addendum to the MSA and a separate implementation fee." Weight loss, then TRT, then hair means paying implementation three times. PharmaBro: unlimited brands on one account, one bill.
• A 12-month initial term. PharmaBro has no term at all.
• No American Express. Their merchant account does not accept it, so neither do you. On your own Stripe, that is your decision.
• Providers cover 7am to 7pm CST, and the proposal notes coverage "does not include holiday coverage."
• Eight states require a synchronous visit before an initial prescription: AR, DC, DE, KS, MS, NM, RI, WV.
• TRT is limited to 30 states and to patients 25 and over, where PharmaBro's non-scheduled coverage runs all 50.
• LegitScript costs $3,000 through their path, or $5,625 standalone. PharmaBro includes it at $0, on every tier.

None of these is disqualifying on its own. Together they describe a relationship in which most of the operating decisions belong to the platform.

The clinical operation behind that fee is real, and the proposal is specific about it: 50-state licensing and credentialing, malpractice coverage, primary-source verification, DEA and NPDB review, a 24/7/365 inbound patient support desk, a multi-layered supply chain, and medication and lab costs carried by OpenLoop rather than by you.

That is a genuine outsourcing of risk and working capital. If you want a partner who funds inventory, absorbs merchant reserves and chargebacks, and runs clinical operations end to end, OpenLoop is selling exactly that, and roughly half your revenue is the honest price of it.

The trade is coherent. It is simply a different business. You are choosing between operating a brand you own and licensing one you are paid a fee to market.

OpenLoop's own schedule pays a brand $124 of a $249 patient payment, and pays it weekly, out of their merchant account, on their count, with your share shrinking as the patient gets more valuable.

PharmaBro charges a published flat fee, takes nothing on the medication, and puts the patient's money in your Stripe account on the day they pay. Everything above that number is yours, and the number does not change when you win.

Published pricing. Your own Stripe. Zero revenue share. Live in 5 days. Unlimited brands, no term, and full export inside 24 hours on any day you ask.